Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies - Saei, A., Palafox, M., Benoukraf, T., Kumari, N., Jaynes, P. W., Iyengar, P. V., Munoz-Couselo, E., Nuciforo, P., Cortes, J., Nötzel, C., Kumarakulasinghe, N. B., Richard, J. L. C., Bin Adam Isa, Z. F., Pang, B., Guzman, M., Siqin, Z., Yang, H., Tam, W. L., Serra, V., Eichhorn, P. J. A. (Rockefeller University Press, 2018)
6297482